Member Info for AquaeSulis01

Bit of good news
https://www.telegraph.co.uk/business/2021/09/14/markets-live-latest-coronavirus-news-pound-euro-ftse-100/
Expert reaction: US CPI rise less than expected
For some analysts, the latest US inflation figures give weight to the argument that inflation is transitory and the upward pressure on the prices paid by consumers is beginning to wane.

Aaron Anderson, SVP of Research at Fisher Investments, comments:

High inflation should prove temporary because it is a supply-chain issue not a monetary-policy issue. Money supply measures have spiked, but they do not necessarily represent spendable money and are not the primary cause of recent inflation.

Prices are likely to moderate once supply-chain issues fade, regardless of how the Fed tweaks monetary policy.

rsi below 30 now

Thought a response to the written question s posed in advance of the investor meets presentation would have been made by now

Ironic that investors have given the benefit of the doubt to Spire Health Care who published this in yesterday's RNS
"Spire said it expected Covid-related costs to be offset by improvements in testing and progressive efficiency measures providing a platform for margin expansion in 2022.
Given the positive underlying trends, we are confident 2021 revenue will be materially above 2019," the company added.
It also expects core earnings to recover from the July and August levels to trade in line with 2019 over the last four months of the year, assuming Covid cases do not rise materially.
Should it do so, the operating impacts seen in July and August could prevail for the rest of the year," Spire said.
Chief executive Justin Ash said the company had seen "unprecedented" demand from private patients as National Health Services waiting lists climbed due to a backlog for routine treatments."

Now Spire describe themselves as "Spire Healthcare is a leading independent hospital group in the United Kingdom, with 39 private hospitals and 8 clinics across England, Wales and Scotland.
Spire Healthcare delivered tailored, personalised care to approximately 750,000 in-patients and daycase patients in 2020, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom."

So who is likely to be supplying those artificial hip and knees replacements?

Who lit the fuse, Guy Fawkes?

Nice to see ESG module to be released this month

Amazed this has gone up less than ITM after such a stunning technology endorsement but surely only a matter of time now before the market properly reacts to this news

Think you'll find Stuart has more than he can cope with dealing with human population, besides, others with deeper pockets have already stolen a march in the animal world.

https://www.cargill.com/2021/cargill-invests-in-animalbiome-better-gut-health-for-pets

The treatment costs £2000 per shot without discount and only 300,000 people are being targeted so little impact on future LPLDL sales worldwide. However, it does flag up the risk SOH takes with his refusal to spend money advertising Opti products to accelerate sales whilst first mover advantage for clinically proven non-statin based products still exist

When you have a lot of Projects in a portfolio and each one is capable of impacting the Market Cap of the company significantly , it should come as no surprise to see the high number of RNS's produced. If they weren't at least capable of affecting the share price then they would be REACH RNS's. This particular update is quite exciting, as the bullseye target is shared by RIO Tinto so should be no problem selling on to that particular party if a significant find is made

Then happy to join in the early Christmas spirit bitcoin; here's hoping the Chuckle Brothers were being serious and deliver on the two mines and regular drill results

Judging by the time of the post it's probably after a few sherberts. No doubt the hangover has now set in not helped by the conspicuous absence of the promised weekly newsflow

Positive further Director buy, and gets all those questions you have long been calling for skid

And it was you mentioned RNS's not me!

Which part of drill results once per week are you not understanding Mr Pedantic.

I did listen to it. Between 9.40-951 Interviewer "Upcoming news flow from ECR, what is it looking like"? Craig "At least one or two items per week, drill results at least once a week"

So what part of that answer am I not hearing properly lucky?

lucky, that statement appears straight after the promised 1 to 2 drilling updates per week which have failed to materialise, so will hope that there are to be mines at both Creswick and Baillieston but in the meantime will treat his comment re mines with a pinch of salt until proven otherwise.

Legalwolf "If shareholders in POW were offered shares in the spinout, that would very much boost the share price here. " I think the opposite would happen if shareholders in POW were offered "free" spinout shares in lieu as you will be removing "value" from POW as an entity rather than leaving the "POW" share holding fully undiluted in the new company. Look what happened to Open Orphan when it made a distribution in specie of the entire issued share capital of its wholly-owned subsidiary Orph Pharma IP Company Limited ("Orph Pharma") to Poolbeg Pharma Limited ("Poolbeg"), in return for the issue of new shares by Poolbeg ("Poolbeg Shares") to shareholders of Open Orphan on the register at close of business on 17 June 2021 ("Relevant Shareholders"), the share price in Open Orphan fell from 36.75p and has only recently rallied to 26.80p following a major contract win

Legal, with the exception of very recent warrant awards to external companies and individuals associated with acquisitions (such as Tati) where the warrants can be exercised at multiples of today's share price, the warrants position as I have it for Directors associated with major fundraises etc is as shown below. Warrant money exercised has raised £3,615,328.00 for the company which has meant there has not had to be any recent fund raises to keep the company in business
Date Warrant Details Option Share Quantity Option Price Trigger Price Expiry Date
28/01/19 Refinancing Business £1M 200000000 1 18/02/21
Mr Brian Moritz, a former non-executive director 6000000 0.5 18/02/21
Andrew Bell options 13613929 1 >1.5 for 5 conseq days 15/02/22
Paul Johnson options 13613929 1 >1.5 for 5 conseq days 15/02/22
SI Capital Limited  2500000 1 18/02/21
SP Angel Limited 2500000 1 18/02/21
10/12/19 Equity Placing and Subscription £700000 175000000 0.7 >2.25 for 10 conseq days POW can trigger 10/12/21
19/02/20 Director Appt Ed Shaw Options 5000000 1 >1.5 for 5 conseq days + 12 mths service 19/02/23
06/07/20 Financing Raise £1M 210526316 0.75 >3 for 5 conseq days Power trigger payment 06/07/22
30/07/20 Andrew Bell options 7500000 2 2 or > for at least 6 months 30/07/23
Paul Johnson options 12500000 2 2 or > for at least 6 months 30/07/23
14/09/20 Canadian Silver Option 9000000 1.75 14/09/23
21/09/20 Canadian Silver Option 5000000 2 If exercised within 12 mths 5p replacement if sp >7.5 for 5 conseq days pow can trigger purchase 21/09/22
15/03/21 Canadian Silver Option 2569641 2.89 15/03/24



TOTAL SUM OF WARRANTS = 665,323,815
TOTAL WARRANTS o/s = 236,844,871

Legal, these warrants date back to a Jan 2019 fundraise when the company was known as African Minerals and the share price at the time was 0.53p. The parties taking part in the fundraise were taken a huge amount of risk at that time as the portfolio was nothing like as promising as it was then. So offering future warrants at twice the then share price was not quite as generous as it now appears. The plus side of warrants for an exploration company that is not generating revenue is that it reduces the need to go back to the market so often to raise yet more money to pay for drilling etc. I have a spreadsheet tracking warrants outstanding and exercised and will post when I have more time